Brian Shaw

1.9k total citations
8 papers, 355 citations indexed

About

Brian Shaw is a scholar working on Genetics, Neurology and Pathology and Forensic Medicine. According to data from OpenAlex, Brian Shaw has authored 8 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 3 papers in Neurology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Brian Shaw's work include Glioma Diagnosis and Treatment (3 papers), CNS Lymphoma Diagnosis and Treatment (2 papers) and Brain Metastases and Treatment (2 papers). Brian Shaw is often cited by papers focused on Glioma Diagnosis and Treatment (3 papers), CNS Lymphoma Diagnosis and Treatment (2 papers) and Brain Metastases and Treatment (2 papers). Brian Shaw collaborates with scholars based in United States, United Kingdom and Germany. Brian Shaw's co-authors include Frederick L. Mansfield, Lawrence F. Borges, James R. Kasser, John E. Hall, C. R. Valeri, Priscilla K. Brastianos, Simon Aylwin, Yazmín Odia, Megha Subramanian and Sandro Santagata and has published in prestigious journals such as Nature Communications, Cancer and Journal of Bone and Joint Surgery.

In The Last Decade

Brian Shaw

7 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian Shaw United States 6 121 80 76 65 65 8 355
Solomon A. Mensah United States 9 43 0.4× 20 0.3× 63 0.8× 93 1.4× 10 0.2× 12 447
Joseph Corkery United States 8 63 0.5× 74 0.9× 11 0.1× 91 1.4× 37 0.6× 8 331
Lisa C. Bachenheimer United States 7 69 0.6× 84 1.1× 25 0.3× 49 0.8× 52 0.8× 8 316
Emine Canyılmaz Türkiye 12 139 1.1× 72 0.9× 5 0.1× 41 0.6× 37 0.6× 31 496
Melanie McCabe White United States 14 196 1.6× 21 0.3× 15 0.2× 46 0.7× 15 0.2× 17 608
Huan–Lun Hsu Taiwan 5 60 0.5× 37 0.5× 4 0.1× 159 2.4× 32 0.5× 10 376
Ariane Melchior‐Becker Germany 9 76 0.6× 44 0.6× 7 0.1× 172 2.6× 17 0.3× 9 395
Ingrid A.M. Relou Netherlands 12 119 1.0× 36 0.5× 25 0.3× 113 1.7× 7 0.1× 14 442
Fatih Yalçın United States 9 19 0.2× 43 0.5× 17 0.2× 77 1.2× 36 0.6× 16 351
Z. Mohr Germany 8 225 1.9× 175 2.2× 4 0.1× 36 0.6× 76 1.2× 16 452

Countries citing papers authored by Brian Shaw

Since Specialization
Citations

This map shows the geographic impact of Brian Shaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Shaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Shaw more than expected).

Fields of papers citing papers by Brian Shaw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Shaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Shaw. The network helps show where Brian Shaw may publish in the future.

Co-authorship network of co-authors of Brian Shaw

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Shaw. A scholar is included among the top collaborators of Brian Shaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Shaw. Brian Shaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Pujade-Lauraine, Éric, Frédèric Selle, Giovanni Scambia, et al.. (2021). LBA33 Maintenance olaparib rechallenge in patients (pts) with ovarian carcinoma (OC) previously treated with a PARP inhibitor (PARPi): Phase IIIb OReO/ENGOT Ov-38 trial. Annals of Oncology. 32. S1308–S1309. 42 indexed citations
2.
Alvarez‐Breckenridge, Christopher, Sanjay M. Prakadan, Albert Kim, et al.. (2021). IMMU-02. GENOMIC AND TRANSCRIPTOMIC CORRELATES OF IMMUNOTHERAPY RESPONSE WITHIN THE TUMOR MICROENVIRONMENT OF LEPTOMENINGEAL METASTASES. Neuro-Oncology. 23(Supplement_6). vi92–vi92.
3.
Ebright, Richard Y., Marcus Zachariah, Douglas S. Micalizzi, et al.. (2020). HIF1A signaling selectively supports proliferation of breast cancer in the brain. Nature Communications. 11(1). 6311–6311. 65 indexed citations
4.
Karschnia, Philipp, Tracy T. Batchelor, Justin T. Jordan, et al.. (2020). Primary dural lymphomas: Clinical presentation, management, and outcome. Cancer. 126(12). 2811–2820. 21 indexed citations
5.
Juratli, Tareq A., Pamela S. Jones, Nancy Wang, et al.. (2019). Targeted treatment of papillary craniopharyngiomas harboring BRAF V600E mutations. Cancer. 125(17). 2910–2914. 66 indexed citations
6.
Burton, Tim, Sonya K. Auer, James H. Hunt, et al.. (2019). Hierarchical analysis of wild Atlantic salmon (Salmo salar) fecundity in relation to body size and developmental traits. Journal of Fish Biology. 96(2). 316–326. 2 indexed citations
7.
Shaw, Brian, et al.. (1993). Reinfusion of shed blood after orthopaedic procedures in children and adolescents.. Journal of Bone and Joint Surgery. 75(3). 363–371. 86 indexed citations
8.
Shaw, Brian, Frederick L. Mansfield, & Lawrence F. Borges. (1989). One-stage posterolateral decompression and stabilization for primary and metastatic vertebral tumors in the thoracic and lumbar spine. Journal of neurosurgery. 70(3). 405–410. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026